Gastric variceal hemorrhage is a serious consequence of end-stage liver disease, which is associated with high morbidity and mortality. 1 The majority of patients with cirrhosis develop varices ...

Methods: A cohort of 304 patients with liver cirrhosis and esophageal varices, who had no previous history of variceal bleeding and no prophylactic therapy, was studied. Conclusions: Variceal ...

A biopsy of the liver was taken, and the pathological examination confirmed the diagnosis of cirrhosis. Pathological examination of the resected portion of the stomach revealed gastric varices.

Liver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...

Aug. 21, 2024 — A research team has shown the benefits of camu-camu on non-alcoholic fatty liver disease. This exotic fruit reduces liver fat ... Liver Transplant Outperforms Other Therapies for ...

Newly diagnosed patients with cirrhosis of the liver but no history of gastrointestinal ... for assessment of esophageal and gastric varices. If esophageal varices were present, their size was ...

Learn how the Baveno VI criteria provide a cost-effective, noninvasive alternative to upper gastrointestinal endoscopy for ...

Four in 10 people are thought to have a potentially serious liver condition known as MASLD. Reversing it is possible if you catch it early. By Nina Agrawal Geraldine Frank was looking forward to ...

This can lead to varices and ascites. • Hepatocellular Carcinoma (HCC): Liver cancer is more common in people with cirrhosis.

In an age of normalized “detoxes” and “cleanses,” supplements marketed to cleanse your liver have garnered popularity in recent years. Proponents of liver cleanses claim it can detoxify ...

blood in the portal venous system attempts to bypass the liver as portal pressure increases. Abnormal connections ...

Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that three abstracts from ongoing Phase 2b/3 adaptive, NAVIGATE trial ...